← FDA DRUG APPROVALS

FDA ANDA · ANDA087118

CHLORTHALIDONE

Sponsor: SANDOZ

APPLICATION
ANDA087118
TYPE
ANDA
ORIGINAL APPROVAL
1994-09-16
LATEST ACTION
1995-04-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORTHALIDONEDiscontinued
CHLORTHALIDONE 50MG · TABLET · ORAL

Approval history

1995-04-18Manufacturing (CMC) · Supplement 16AP
1995-04-18Manufacturing (CMC) · Supplement 17AP
1994-09-16OriginalAP
1991-03-27Bioequivalence · Supplement 21AP
1988-05-23Manufacturing (CMC) · Supplement 15AP
1986-01-08Manufacturing (CMC) · Supplement 13AP
1983-04-22Manufacturing (CMC) · Supplement 9AP
1982-11-03Manufacturing (CMC) · Supplement 5AP
1982-08-23Manufacturing (CMC) · Supplement 2AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →